Clinical Trials Directory

Trials / Unknown

UnknownNCT00767923

Validation of OxyVu for Assessing Level of Amputation With Comparison to Other Modalities

Clinical Validation of HyperMed OxyVu Tissue Oximeter for Assessing Level of Amputation With Comparison to Other Modalities

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
HyperMed · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

Correlation of(OxyVu) values to to ABI, TBP, and TCOM in patients scheduled for foot level amputation because of critical limb ischemia, infection, or tissue necrosis.

Detailed description

The purpose of this clinical study is to correlate tissue oxygenation values measured with a hyperspectral imaging system (OxyVu) to Ankle Brachial Indices (ABI), toe pressures (TBP), and transcutaneous oxygen monitoring (TCOM) in patients scheduled for foot level amputation because of critical limb ischemia, infection, or tissue necrosis.

Conditions

Timeline

Start date
2008-07-01
Primary completion
2009-02-01
Completion
2010-02-01
First posted
2008-10-07
Last updated
2009-06-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00767923. Inclusion in this directory is not an endorsement.